Table 3.

Main and Interactive Effects of Premenstrual Symptoms and Anxiety Sensitivity Predicting PTSD Symptoms

	R2	95% CI	ΔR2	t	β	sr2	p
DV: CAPS–Total score
Step 1	.25	.07, .43	.245				.001
BFI–Neuroticism				3.35	.42	.11	.002
PTEs				1.85	.22	.06	.07
Panic group				.45	.06	.00	.66
Step 2	.38	.20, .56	.131				.04
MDQ				3.31	.49	.17	.002
ASI				.06	.01	.00	.96
Step 3	.42	.25, .59	.047				.02
MDQ by ASI interaction term				2.04	.24	.08	.04
DV: CAPS–Reexperiencing
Step 1	.25	.08, .41	.246				.001
BFI–Neuroticism				3.03	.38	.14	.004
PTEs				2.60	.31	.11	.01
Panic group				.05	.01	.00	.96
Step 2	.34	.17, .51	.089				.036
MDQ				2.58	.38	.11	.01
ASI				.66	.09	.00	.51
Step 3	.41	.25, .57	.071				.02
MDQ by ASI interaction term				2.50	.30	.11	.02
DV: CAPS–Avoidance
Step 1	.08	−.04, .20	.082				.19
BFI–Neuroticism				.09	.02	.00	.93
PTEs				−.13	−.02	.00	.90
Panic group				−.89	−.12	.01	.38
Step 2	.16	.01, .31	.082				.09
MDQ				2.09	.36	.08	.04
ASI				.80	.13	.01	.43
Step 3	.17	.02, .32	.010				.42
MDQ by ASI interaction term				.81	.11	.01	.42
DV: CAPS–Hyperarousal
Step 1	.18	.01, .34	.182				.01
BFI–Neuroticism				2.69	.35	.12	.009
PTEs				1.02	.13	.02	.31
Panic group				.92	.12	.02	.36
Step 2	.38	.20, .56	.20				.001
MDQ				4.00	.59	.24	<.001
ASI				−.72	−.10	.01	.47
Step 3	.38	.21, .55	.005				.52
MDQ by ASI interaction term				.64	.08	.01	.52
DV: CAPS–Numbing
Step 1	.15	−.01, .31	.151				.03
BFI–Neuroticism				2.67	.35	.11	.01
PTEs				.45	.06	.00	.66
Panic group				.57	.08	.01	.57
Step 2	.20	.04, .36	.047				.22
MDQ				1.68	.28	.05	.10
ASI				−.56	−.09	.01	.58
Step 3	.26	.09, .43	.066				.04
MDQ by ASI interaction term				2.15	.28	.08	.04